Abstract: Embodiments of the invention relate to polycrystalline diamond bodies having nanoparticles disposed in a region therein, and methods of fabricating the same.

Abstract: In one aspect, sintered cemented carbide compositions are described herein exhibiting desirable wear resistance without deleterious losses in fracture toughness. Such cemented carbide compositions can be employed as tooling in a variety of applications including earth boring and mining operations as well as machining various metals and alloys. For example, a sintered cemented carbide composition described herein comprises a hard particle phase including tungsten carbide and a cobalt-based metallic binder comprising a cubic cobalt-molybdenum solid solution phase.

Abstract: A ceramic matrix composite includes continuous silicon carbide fibers in a ceramic matrix comprising silicon carbide and a MAX phase compound having a chemical composition Mn+1AXn, where M is a transition metal selected from the group consisting of: Ti, V, Cr, Sc, Zr, Nb, Mo, Hf, and Ta; A is a group-A element selected from the group consisting of: Al, Si, P, S, Ga, Ge, As, Cd, In, Sn, Tl and Pb; and X is carbon or nitrogen, with n being an integer from 1 to 3.

Abstract: A method of forming one or more high temperature co-fired ceramic articles, comprising the steps of: —a) forming (34) a plurality of green compacts, by a process comprising dry pressing a powder comprising ceramic and organic binder to form a green compact; b) disposing (38) a conductor or conductor precursor to at least one surface of at least one of the plurality of green compacts to form at least one patterned green compact; c) assembling the at least one patterned green compact with one or more of the plurality of green compacts or patterned green compacts or both to form a laminated assembly; d) isostatically (40) pressing the laminated assembly to form a pressed laminated assembly; e) firing (42) the pressed laminated assembly at a temperature sufficient to sinter the ceramic layers together.

Abstract: The coatings of the invention provide potassium in a readily available form in combination with other nutrients that promote early plant growth and health. The potassium-based fertilizer product which comprises: potassium, zinc, manganese and iron. Calcium may also be added. The mixture is applied in a 325 MESH or finer powder to suitable agronomic carriers.

Abstract: A material for optimizing and maintaining at least one of water, nutrients, biocides, and other protectant or growth supporting chemicals in natural soils by decreasing leaching, evaporation, and volatility through application of agglomerated granules (prills) formed of engineered hydrating particles, a binder, nutrients, and protectants to the soil. Typical application is by applying prills simultaneously with seeds when drilled, broadcast, or otherwise distributed.

Abstract: Provided herein is a symmetric amino triazine for use as a fuel and ignition source in chemically initiated illuminates or igniters. 3-amino-1,2,4-triazine act as a fuel and generates enough heat on exposure to as little as one drop of one hundred percent nitric acid to spontaneously ignite.

Abstract: Provided is a melt-castable binder useful for stabilizing high energy explosive materials. A melt-castable nitramine binder has high energy in its own right yet is very insensitive to accidental detonation such as by shock or friction. The melt-castable nitramine binder is optionally combined with one or more high energy materials in the formation of an explosive composition with improved energy yield and safety and handling parameters relative to the high energy material alone.

Abstract: A propellant load includes a propellant block, containing energetic charges in a crosslinked binder, arranged in a structure having a thermal protection; the crosslinked binder being an energetic binder including a polymer, more polar than hydroxytelechelic polybutadiene (HTPB), which is crosslinked and an energetic plasticizer, the polymer non-crosslinked representing less than 14% of the volume of the propellant block; a bonding layer, based on crosslinked hydroxytelechelic polybutadiene (HTPB), between the thermal protection and the propellant block; and a system for mechanical reinforcement of the bonding layer/propellant block bond, present on at least part of the bonding layer/propellant block interface, including grains embedded in part in the bonding layer and the complementary part thereof being embedded in the propellant block: made of a pyrotechnically inert material, and that has a surface energy greater than 34 mJ/m2; and the largest dimension of which is between 0.3 and 5.2 mm.

Abstract: Disclosed are methods and systems for converting chloromethane to olefins. A method includes contacting an aluminosilicate catalyst having a chabazite zeolite structure with a feed that includes an alkyl halide and is substantially free of oxygenates under reaction conditions sufficient to produce an olefin hydrocarbon product comprising C2-C4 olefins.

Abstract: Implementations of the disclosed subject matter provide a process for the aromatization of a methane-containing gas stream may include contacting the methane-containing gas stream in a reaction zone comprising an aromatization catalyst particulate and an inert heat carrier particulate under methane-containing gas aromatization reaction conditions to produce a product stream comprising aromatics in the reaction zone. The inert heat carrier particulate may be separated from the aromatization catalyst particulate in a separation zone under separation conditions. The aromatization catalyst particulate may have a first minimum fluidization velocity and the inert heat carrier particulate may have a second minimum fluidization velocity which may be greater than the first minimum fluidization velocity. The ratio of the second minimum fluidization velocity to the first minimum fluidization velocity may be less than 200 and may be more than 15.

Abstract: Implementations of the disclosed subject matter provide a process for the aromatization of a methane-containing gas stream including contacting the methane-containing gas stream in a reaction zone comprising an aromatization catalyst particulate and a hydrogen acceptor particulate under methane-containing gas aromatization reaction conditions to produce reaction products comprising aromatics and gaseous hydrogen. At least a portion of the gaseous hydrogen produced is bound by the hydrogen acceptor particulate in the reaction zone and removed from the reaction products in the reaction zone. Further, the hydrogen acceptor particulate may be separated from the aromatization catalyst particulate in a separation zone under separation conditions.

Abstract: A method for producing C2 hydrocarbons comprising (a) introducing a reactant mixture to a reactor comprising a catalyst, wherein the reactant mixture comprises CH4, O2 and a heavy diluent, and wherein the reactant mixture is characterized by a bulk CH4/O2 molar ratio; (b) allowing the reactant mixture to contact a surface of the catalyst and react via an oxidative coupling of CH4 (OCM) reaction to form a product mixture, wherein the reactant mixture is characterized by a local CH4/O2 molar ratio on the catalyst surface, wherein the local CH4/O2 molar ratio is greater than the bulk CH4/O2 molar ratio, wherein the product mixture comprises C2 hydrocarbons, and wherein a selectivity to C2 hydrocarbons is increased by at least about 1% when compared to a selectivity of an otherwise similar OCM reaction conducted in the absence of the heavy diluent; and (c) recovering the product mixture from the reactor.

Abstract: In a system for hydrogenation of an aromatic compound, an excessive temperature rise in the hydrogenation reaction unit is prevented, and the amount of the dilution gas to be circulated is minimized. The hydrogenation system (1) comprises a hydrogenation reaction unit (2) for producing a hydrogenated aromatic compound by adding hydrogen to an aromatic compound via a hydrogenation reaction, a separation unit (3) for separating the hydrogenated aromatic compound from a product of the hydrogenation reaction unit, and a transportation unit (4) for circulating at least a part of a residual component remaining in the separation unit after separating the hydrogenated aromatic compound therefrom to the hydrogenation reaction unit.

Abstract: The present invention provides a method that produces a composition containing 1223xd and/or 1213xa by a gas-phase reaction, and that achieves production efficiency higher than known methods. The present invention provides a method for producing a composition containing at least one fluorine-containing olefin selected from 1,2-dichloro-3,3,3-trifluoropropene (HCFO-1223xd) and 1,1,2-trichloro-3,3,3-trifluoropropene (CFO-1213xa), the method comprising subjecting at least one starting compound selected from a chlorine-containing alkane represented by Formula (1-1): CF3CHXCHX2, wherein each X is independently H or Cl, with the proviso that at least one X represents Cl, and a chlorine-containing alkene represented by Formula (1-2): CF3CX?CX2, wherein each X is independently H or Cl, with the proviso that at least one X represents Cl, to a gas-phase oxychlorination reaction in a temperature range of 380° C. or lower in the presence of oxidative gas and hydrogen chloride gas.

Abstract: The present invention relates, in part, to the discovery that the presence of HF in a HCFC-244bb feedstream in a reaction for the preparation of HFO-1234yf results in selectivity changeover from HFO-1234yf to HCFO-1233xf. By substantially removing HF, it is shown that the selectivity to HFO-1234yf via dehydrochlorination of HCFC-244bb is improved.

Abstract: Process for the production of alkenols comprising the dehydration of at least one diol in the presence of at least one catalyst based on cerium oxide, wherein said catalyst based on cerium oxide is obtained by precipitation, in the presence of at least one base, of at least one compound containing cerium. Preferably, said diol may be a butanediol, more preferably 1,3-butanediol, still more preferably bio-1,3-butanediol derived from biosynthetic processes. Said alkenols may advantageously be used for the production of 1,3-butadiene, in particular of bio-1,3-butadiene.

Abstract: The invention relates to a method for producing butanol through microbial fermentation, in which the butanol product is removed by extraction into a water immiscible organic extractant during the fermentation. The invention also relates to a method for producing butanol through microbial fermentation, in which the butanol product is removed during the fermentation by extraction into a water-immiscible extractant composition. The invention further relates to compositions comprising a solution of butanol in a water immiscible organic extractant composition.

Abstract: Disclosed is (i) a process of making phenol and/or cyclohexanone from cyclohexylbenzene including a step of removing methylcyclopentylbenzene from (a) the cyclohexylbenzene feed supplied to the oxidation step and/or (b) the crude phenol product (ii) a phenol composition and (iii) a cyclohexylbenzene composition that can be made using the process.

Abstract: A polyphenol derivative of the stilbenoid family, namely trans-3,5,4?-trihydroxybibenzyl, also known as dihydro-resveratrol, is disclosed as a remedial agent. In particular, the usage of dihydro-resveratrol as an anti-fibrotic agent in suppressing the activation of pancreatic stellate cells (PSCs) is presented. One embodiment also relates to the management of pancreatic fibrosis, which is often accompanied with chronic pancreatitis and desmoplastic reaction of pancreatic cancer. Another embodiment has applications in preventing or alleviating or treating pancreatic cancer or pancreatogenic diabetes.

Abstract: The present invention relates to a process for preparing aldehydes and ketones by carbon-carbon bond cleavage of alkenes, wherein the process is catalysed by first row transition metal nitro coordinated polyoxometalate catalyst. The catalyst can be prepared by pre-treatment of aqua coordinated polyoxometalates with NO2, or they are formed in situ when the reactions are carried in nitroalkanes under aerobic conditions, or they are formed in situ from nitrosyl (NO) compounds in the presence of O2.

Abstract: Methods and systems for suppressing coking in dehydration reactions catalyzed by solid acids. Dehydration reactions catalyzed by one or more solid acid catalysts can be performed in the presence of a super critical carbon dioxide medium which prevents or minimizes coking of the solid acid catalysts. Methods and systems are provided for producing glycerol products, such as acrolein, acrylic acid, acetol, by performing a dehydration reaction of glycerol using one or more solid acid catalysts in the presence of a super critical carbon dioxide reaction medium. Such methods and systems can be nm for extended periods of time, or continuously, due to catalyst regeneration and/or recycling. Such methods and systems are configured to produce glycerol products from crude glycerol feedstock with minimal pretreatment.

Abstract: Methods are provided for synthesis of abscisic acid and 8? analogues thereof (including an enantiopure 8?-acetylene analogue) including methods wherein the previously reported first step of oxidation of 2,6-dimethylphenol (VI) to 2,6-dimethylbenzoquinone, mono ketal (VII) is replaced by a novel two step process comprising (i) oxidation of 2,6-dimethylphenol (VI) using potassium peroxymonosulfate with a catalytic amount of iodobenzene to produce 2,6-dimethylbenzoquinone (XVI) and (ii) ketalization of 2,6-dimethylbenzoquinone (XVI) using ethylene glycol, trimethylorthoformate with a catalytic amount of p-toluenesulfonic acid to produce 2,6-dimethylbenzoquinone, mono ketal (VII).

Abstract: Hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof are dehydrated using a catalyst and a method to produce bio-acrylic acid, acrylic acid derivatives, or mixtures thereof. A method to produce the dehydration catalyst is also provided.

Abstract: Hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof are dehydrated using a catalyst and a method to produce bio-acrylic acid, acrylic acid derivatives, or mixtures thereof. A method to produce the dehydration catalyst is also provided.

Abstract: To provide a novel method for producing a halogenated acrylic acid derivative. A compound represented by the formula (1): (wherein each of R1 and R2 which are independent of each other, is a hydrogen atom or a monovalent group essentially containing a carbon atom, or R1 and R2 together form a ring, R3 is a monovalent group capable of being desorbed by R3OH removal reaction, and each of R4 and R5 which are independent of each other, is a hydrogen atom or a monovalent group essentially containing a carbon atom) and having a boiling point of at most 500° C.

Abstract: The present disclosure provides a method for producing organic compounds, such as esters, from an organic feedstock that includes at least one of a biopolymer or a lipid. The method includes heating the feedstock in the presence of a solid catalyst, such as a solid, inorganic Lewis acid catalyst, and reaction medium that includes an alcohol. At least certain ester products have an ester group corresponding to a substituent of the alcohol.

Abstract: The present disclosure provides a process for producing dimethyl carbonate with high conversion rate. Alkylene glycol reacts with urea via alcohylysis reaction to produce alkylene carbonate and ammonia. The alkylene carbonate produced reacts with methanol via transesterification reaction to produce dimethyl carbonate. Before the dimethyl carbonate is separated from the mixture, the nitrogen-containing impurities are substantially removed. Unreacted feedstock and catalysts are recycled in the process.

Abstract: Provided herein are estolide base oils and oligomeric compounds prepared from processes that include cross metathesis.

Abstract: A skin-protection composition is shown that comprises stilbenoid(s) and/or stilbenoid-containing extract(s) obtained from Dendrobium plants, such as Dendrobium officinale and Dendrobium nobile for the management of melanogenesis, skin-darkening and skin-aging. More particularly, the usage of Dendrobium ingredients and stilbenoids is shown to reduce the formation of melanin in melanocytes. The usage of Dendrobium ingredients and stilbenoids is also shown to reduce the generation of reactive oxygen species and oxidative free radicals. The use of Dendrobium-derived extracts or ingredients or stilbenoids is shown in the formulation of skin-protection, skin-whitening and/or anti-skin aging products.

Abstract: In a process for effecting reductive amination by reacting a carbonyl compound with a secondary amine and hydrogen, the reaction is carried out as a continuous operation and the reaction mixture comprising the carbonyl compound, the secondary amine and hydrogen is contacted first with an acidic fixed bed and then with a fixed bed of hydrogenation catalyst (hereinafter referred to as a hydrogenation fixed bed).

Abstract: Processes and reaction mixtures including non-aqueous solvent mixtures are presented. Non-aqueous solvent mixtures including fluoride salt and non-aqueous solvent combinations are provided that possess high fluoride ion concentrations useful for a range of applications, including organic synthesis. Further non-aqueous solvent mixtures are provided including a salt possessing a non-fluoride anion and a non-aqueous solvent that, when contacted with aqueous fluoride-containing reagents, extract fluoride ions to form non-aqueous fluoride-ion solutions possessing high fluoride-ion concentrations. The salts include an organic cation that does not possess a carbon in the ?-position or does not possess a carbon in the ?-position having a bound hydrogen. This salt structure facilitates its ability to be made anhydrous without decomposition. Example anhydrous fluoride salts include (2,2-dimethylpropyl)trimethylammonium fluoride and bis(2,2-dimethylpropyl)dimethylammonium fluoride.

Abstract: Highly efficient methods for synthesis of levomethadone hydrochloride or dextromethadone hydrochloride are provided starting from D-alanine, or L-alanine, respectively, with retention of configuration. Methods for treating a subject are provided comprising administering a composition comprising an effective amount of levomethadone hydrochloride having not more than 10 ppm dextromethadone.

Abstract: Naphthalenyl benzamide derivatives according to formula I are described, wherein Ar is an aryl or heteroaryl group, and R1-R4 are independently selected from H, halogen, CF3, hydroxyl, C1-C4 alkyl, and C1-C4 oxyalkyl, or a pharmaceutically acceptable salt thereof. The naphthalenyl benzamide derivatives can be used for the treatment of cancer in a subject.

Abstract: Synthesis methods to produce a series of carboxamides built off of an (S)-2-amino acid backbone or an (R)-2-amino acid backbone, depending upon the desired diastereomer of the end product.

Abstract: The invention relates to compounds of the formula and to a process for making same and to the use of the products in the solid phase peptide synthesis. The compounds of formula I are versatile peptide intermediates for the solid phase peptide synthesis (SPPS) of peptide drugs which comprise a Glu-fatty alkyl side chain building block attached to a Lys-part of the peptide chain.

Abstract: The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In some embodiments, the invention provides a compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating thrombosis by administering an antithrombotic compound that preferentially binds to a thromboxane receptor, has preferential binding for either TPalpha (TP?) or TPbeta (TP?) receptor subtype.

Abstract: The present invention relates to novel N-arylamide-substituted trifluoroethyl sulfide derivatives of the formula (I) in which X1, X2, X3, X4, R1, R2, R3, n have the meanings given in the description—to their use as acaricides and insecticides for controlling animal pests and to processes and intermediates for their preparation

Abstract: The present invention provides a production intermediate of an atropisomer of a pyrrole derivative having excellent mineralocorticoid receptor antagonistic activity, a method for producing the same, and a crystal thereof. A method for producing an atropisomer of a pyrrole derivative including a step of resolving a compound represented by the following general formula (I) [wherein R1 represents a methyl group or a trifluoromethyl group, R2 represents a hydrogen atom or a C1-C3 alkoxy group, and n represents an integer selected from 1 to 3] into its atropisomers, characterized by using an optically active amine having a cinchonine skeletal formula, and a crystal of (S)-1-(2-hydroxyethyl)-4-methyl-N-[4-(methylsulfonyl)phenyl]-5-[2-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide.

Abstract: The present invention provides novel crystalline forms of apremilast hemitoluene solvate, apremilast hydrate, and apremilast anhydrate and an amorphous form of apremilast, and processes for the preparation of these forms.

Abstract: The present invention provides novel polymorphs of Lomitapide, process for their preparation and pharmaceutical compositions comprising them. The present invention also provides a novel polymorph of Lomitapide mesylate, process for its preparation and pharmaceutical compositions comprising it.

Abstract: The present invention relates to a process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate.

Abstract: The present invention is directed to novel processes for the preparation of histamine H3 receptor modulators, in the treatment of for example, cognitive disorders, sleep disorders and/or psychiatric disorders.

Abstract: A problem of the present invention is to provide a new compound which has NK1 receptor antagonist activity, whose CYP3A4 inhibitory activity is reduced compared to aprepitant, and which are useful for the prevention or treatment of cancer-chemotherapy-induced nausea and vomiting. That is, the present invention relates to cyclohexyl pyridine derivatives represented by the following formula (I) or a pharmaceutically acceptable salt thereof. wherein, ring A is 4-fluoro-2-methylphenyl or the like; X is a hydrogen atom or the like; R1 is carboxymethyl or the like; R2 is alkyl or the like; Y is 0-2 or the like; U is —N(CH3)COC(CH3)2-3,5-bistrifluoromethylphenyl or the like.

Abstract: The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof wherein: X1 is H, Br, Cl, or X2 is H, Br, Cl, or n1 is 1-2; and n2 is 1-2.

Abstract: Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the CB1 receptor. Such compounds are represented by Formula (I) wherein R1, R2, R3, L1, n, v, r, w, and g are defined herein. and further represented by Formula (II) wherein the group “X?Y”, ring A, R10, R11, R30, W, and t are defined herein.

Abstract: The present subject matter relates to solvates and the amorphous form of bosutinib; the solvates namely being a propylene glycol solvate and an acetonitrile solvate. Also provided are processes for preparing the propylene glycol solvate, the amorphous form and the crystalline acetonitrile solvate of bosutinib; as well as compositions comprising said forms. Bosutinib is a 3-quinolinecarbonitrile kinase inhibitor and is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CMS) with resistance or intolerance to prior therapy.

Abstract: The present invention is directed to processes and intermediates useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea (Compound I), crystalline forms and solvate forms thereof; and compositions comprising 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea, crystalline forms and solvate forms thereof prepared by processes as described herein.

Abstract: The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.

Abstract: Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.